Clinical Trial Detail

NCT ID NCT03336606
Title Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Providence Health & Services
Indications

head and neck squamous cell carcinoma

melanoma

Therapies

Tavolimab

Age Groups: adult senior

No variant requirements are available.